Search results for "mRNA Safety Concerns"

while covering protests and recounts editorial resistance and content removal when reporting on vaccine safety Harding testified that during the early vaccine rollout he attempted to publish articles raising concerns about the speed of vaccine development and the use of mRNA technology. stated that submissions were rejected or discouraged by editorial outlets citing source credibility concerns

breakthrough data, pediatric myocarditis modeling, biodistribution spike protein, reverse transcription concern and biodistribution concerns were inadequately studied, and that he faced professional consequences testified that shortly after relocating from the Mayo Clinic to Calgary in February 2020, he became concerned He raised concerns regarding antibody-dependent enhancement, immune imprinting, and evolutionary pressure He also discussed biodistribution findings, stating that mRNA and spike protein were detected beyond

Witness Testimony Keywords from Transcript pandemic definition change, PCR cycle threshold concerns, novel virus, criticized changes to the definition of a pandemic to include case counts, and expressed concerns He characterized mRNA vaccines as experimental gene therapy products and argued that emergency use authorization He further stated that adverse event reporting was discouraged, potentially obscuring safety signals.

, Pfizer Vaccine, Adverse Event, Myocarditis, Pericarditis, Cardiology Referral, Medical Exemption, mRNA He stated that he received his first COVID-19 vaccine dose under pressure due to concerns about losing

Ivermectin Advocacy, Hydroxychloroquine Debate, Lockdown Ineffectiveness Claim, Sweden Comparison Model, mRNA Tucker testified that mRNA vaccines were presented as a transmission-blocking solution but did not prevent

, 2023 Day 1 : April 13, 2023 Winnipeg Day One: Full Day Testimony Testimony alleging unprecedented safety signals in VAERS following COVID-19 mRNA rollout, concerns about spike protein toxicity, lipid nanoparticle Scientific and personal testimony criticizing pandemic policies, PCR testing practices, mRNA vaccine Concerns regarding censorship, pediatric COVID-19 vaccination policy, and government response including Retirement from the Canadian Armed Forces following refusal to comply with COVID-19 vaccination mandate and concerns

and Efficacy of the COVID-19 Response in Canada; November 2023 Main Topic Harm–Benefit Analysis of mRNA specializing in harm–benefit analysis, testified regarding his published reanalysis of the Pfizer and Moderna mRNA

Unvaccinated” label incident, vaccine coercion claim, Johnson & Johnson vaccine choice, pericarditis history concern , post-vaccination arthritis flare, informed consent concerns, shifting public health messaging Included He testified that he had a history of pericarditis and was hesitant about mRNA vaccines due to reported

testimonies and findings from the 2023 NCI Report underscore the need for: Immediately Discontinuing Use of mRNA

22, 2023 Day 1 : April 20, 2023 Saskatoon Day One: Full Day Testimony Ethical, clinical, and policy concerns concerns. Protest-related fines, hospitalization with COVID-19, interprovincial transfer, and concerns regarding Regulatory classification, manufacturing quality control, and safety assessment concerns related to mRNA Personal experiences of medical discrimination, pregnancy-related healthcare concerns, and civic activism

These concerns were echoed and substantiated by the evidence and the findings detailed in the November Hodkinson raised concerns about the long-term health risks of the COVID-19 vaccines, including increased This trend was alarming and significantly higher than pre-vaccination periods, raising concerns about the vaccine’s safety for young, healthy individuals. safety of COVID-19 vaccines, particularly concerning long-term health effects and the phenomenon of

Issues Introduction The testimonies from the recent NCI hearings in Regina brought to light significant concerns and the effectiveness of the systems in place to monitor and address these concerns. The November 28, 2023 NCI Report corroborates these concerns with substantial evidence. The inclusion of SV40, a known cancer-causing agent, was particularly concerning. Dr. This raises significant concerns about the impact of the vaccines on women’s health, particularly regarding